Novel liquid chromatography-tandem mass spectrometry method for simultaneous detection of anti-hiv drugs lopinavir, ritonavir, and tenofovir in plasma

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 5, 2014, Pages 2675-2680

  Koehn, Josefin ^a   Ho, Rodney J Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; CYHEPTAMIDE; LOPINAVIR; METHANOL; RITONAVIR; TENOFOVIR; WATER; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PHOSPHONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SELECTIVITY; DRUG SENSITIVITY; DRUG SOLUBILITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MACACA NEMESTRINA; MEASUREMENT ACCURACY; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; PROCEDURES;

ADENINE; ANIMALS; ANTI-HIV AGENTS; CHROMATOGRAPHY, LIQUID; LOPINAVIR; MACACA NEMESTRINA; ORGANOPHOSPHONATES; RITONAVIR; TANDEM MASS SPECTROMETRY; TENOFOVIR;

EID: 84898609027     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02748-13     Document Type: Article

References (19)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Ashman DJ, Holmberg SD, The HIV Outpatient Study Investigators. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338: 853-860. http://dx.doi.org/10.1056/ NEJM199803263381301.
2. Yeni P. 2006. Update on HAART in HIV. J. Hepatol. 44(Suppl 1):100-103. http://dx.doi.org/10.1016/j.jhep.2005.11.021.
3. World Health Organization. 9 September 2013, accession date. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. WHO, Geneva, Switzerland. http://www.who.int/hiv/pub/guidelines/ arv2013/download/en/index.html.
4. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. 2012. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA Panel. JAMA 308:387-402. http://dx.doi.org/10.1001/jama.2012.7961.
5. Wang PG, Wei JS, Kim G, Chang M, El-Shourbagy T. 2006. Validation and application of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-Automated 96-well liquidliquid extraction. J. Chromatogr. A 1130:302-307. http://dx.doi.org/10.1016/j.chroma.2006.07.071.
6. Holmstock N, Annaert P, Augustijns P. 2012. Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice. Drug Metab. Dispos. 40:1473-1477. http://dx.doi.org/10.1124/dmd.112.044677.
7. Rouzes A, Berthoin K, Xuereb F, Djabarouti S, Pellegrin I, Pellergrin JL, Coupet AC, Augagneur S, Budzinski H, Saux MC, Breilh D. 2004. Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B 813:209-216. http://dx.doi.org/10.1016/j.jchromb.2004.09.041.
8. Temghare GA, Shetye SS, Joshi SS. 2009. Rapid and sensitive method for quantitative determination of lopinavir and ritonavir in human plasma by liquid chromatography-tandem mass spectrometry. EJ. Chem. 6:223-230. http://dx.doi.org/10.1155/2009/709478.
9. Ehrhardt M, Möck M, Haefeli WE, Mikus G, Burhenne J. 2007. Monitoring of lopinavir and ritonavir in peripheral blood mononuclear cells, plasma and ultrafiltrate using a selective and highly sensitive LC/MS/MS assay. J. Chromatogr. B 850:249-258. http://dx.doi.org/10.1016/j.jchromb.2006.11.037.
10. Colombo S, Beguin A, Telenti A, Biollaz J, Buclin T, Rochat B, Decosterd LA. 2005. Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B 819:259-276. http://dx.doi.org/10.1016/j.jchromb.2005.02.010.
11. Delahunty T, Bushman L, Fletcher CV. 2006. Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS. J. Chromatogr. B 830:6-12. http://dx.doi.org/10.1016/j.jchromb.2005.10.015.
12. Matta MK, Burugula L, Pilli NR, Inamadugu JK, Jvln SR. 2012. A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr. 26:1202-1209. http://dx.doi.org/10.1002/bmc.2679.
13. Durand-Gasselin L, Van Rompay KK, Vela JE, Henne IN, Lee WA, Rhodes GR, Ray AS. 2009. Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys. Mol. Pharm. 6:1145-1151. http://dx.doi.org/10.1021/mp900036s.
14. Kearney BP, Mathias A, Mittan A, Sayre J, Ebrahimi R, Cheng AK. 2006. Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir. J. Acquir. Immune. Defic. Syndr. 43:278-283. http://dx.doi.org/10.1097/01.qai.0000243103.03265.2b.
15. Kiser JJ, Carten ML, Aquilante CL, Anderson PL, Wolfe P, King TM, Delahunty T, Bushman LR, Fletcher CV. 2008. The effect of lopinavir/ ritonavir on the renal clearance of tenofovir in HIV-infected patients. Clin. Pharmacol. Ther. 83:265-272. http://dx.doi.org/10.1038/sj.clpt.6100269.
16. Pruvost A, Negredo E, Théodoro F, Puig J, Levi M, Ayen R, Grassi J, Clotet B. 2009. Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir. Antimicrob. Agents Chemother. 53:1937-1943. http://dx.doi.org/10.1128/AAC.01064-08.
17. Jung BH, Rezek NL, Bridges AS, Corbett AH, Kashuba ADM. 2007. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. Biomed. Chromatogr. 21:1095-1104. http://dx.doi.org/10.1002/bmc.865.
18. Department of Health and Human Services, U.S. Food and Drug Administration. May 2001. Guidance for industry, bioanalytical method validation. Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Rockville, MD.
19. Clinical and Laboratory Standards Institute. October 2004. Protocols for determination of limits of detection and limits of quantification, approved guideline. CLSI document EP17-A. CLSI, Wayne, PA.